Usability and Satisfaction With an Electronic Survey Administration Application in General Population

NCT04102384 | Unknown

• 1 other identifier: 2019P002811
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of the study is to assess the usability and satisfaction of an electronic patient reported outcomes (e-PRO) mobile application. The secondary aim is to assess and compare response rates between two study groups (e-PRO group vs REDCap survey group). A potential differentiating factor between delivering surveys via smart phone and other electronic modes of delivery is the perceived advantage of being able to conveniently complete survey questionnaires at any time and any location. This could help address certain limitations of the quantitative survey method such as recall bias. Furthermore, the portability, connectivity and ubiquity of smartphones may reduce the amount of training or instructions required for users to complete a survey questionnaire on a smartphone.

Conditions

Surveys; Usability; Healthy

Keywords

Electronic Patient Reported Outcomes

Outcome Measures

Primary Outcomes (1)

• Usability of e-PRO vs. emailed link: survey

  A survey will be administered to compare groups on their experiences with the survey-method administration (Investigator developed survey). The following components will be taken into account: acceptability-- participant satisfaction with various aspects of the solution (e.g. content, complexity, comfort, delivery, and credibility). Adoption-- participants' intention to try; perceived barriers and facilitators for uptake. Appropriateness-- participant's perceived relevance to need; suitability to daily patient workflow. Feasibility-- suitability for using daily, weekly etc. This survey is not a scored survey.

  At close-out

Secondary Outcomes (1)

• Survey response rate e-PRO vs emailed link

  At close-out

Study Arms (2)

Control Group

NO INTERVENTION

Participants will be enrolled for a period of 4 weeks. At baseline, we will collect demographic information on participants. During the study, participants will be asked to fill out daily and weekly surveys using an electronically link sent via email. Additionally, participants will be asked to fill out one survey once a week during the study period.

Intervention Group

EXPERIMENTAL

Participants will be enrolled for a period of 4 weeks. At baseline, we will collect demographic information on participants. During the study, participants will be asked to fill out daily and weekly surveys using the e-PRO app. Additionally, participants will be asked to fill out one survey once a week during the study period. A subgroup of these participants will be asked to complete an additional interview to collect more information on their experiences using the mobile app.

Other: e-PRO App

Interventions

e-PRO App OTHER

The e-PRO app is designed to further facilitate the delivery of PRO instruments in a convenient manner to participants. Through its computing capability, and user-friendly interface, the e-PRO app can collect data and implement complex scoring requirements, thus supporting the delivery of self-administered survey questionnaires.

Intervention Group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Healthy participants over the age of 18-65 years as assessed by the Self-Rated Health Measure.
• Fluency in English language to be able to read, understand study procedures and complete surveys administered during the study.
• Willing to travel to the downtown Boston area to participate in up to two study visits.
• Willing to participate in the research study and sign informed consent.

You may not qualify if:

• Participants with a "fair" or "poor" rating on the Self-Rated Health Measure.
• Participants with EU citizenship or permanent residency
• Participants with severe cognitive, vision, hearing, or speech problems that may prevent them from answering surveys
• Participants with serious psychiatric conditions (moderate or major depressive disorder that may impair their ability to complete surveys
• Participants with any terminal illness (e.g. cancers)
• Patients with implantable devices, pacemakers or body worn electronic medical devices

Sponsors & Collaborators

• Massachusetts General Hospital: lead
• Cenduit LLC: collaborator

Study Sites (1)

Partners Healthcare

Boston, Massachusetts, 02114, United States

Location

Study Officials

• Ramya S Palacholla, MD, MPH

  Partners HealthCare

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Ramya S Palacholla, MD, MPH

CONTACT

617-724-0428; RPALACHOLLA@mgh.harvard.edu

Amanda J Centi, P.h.D

CONTACT

617-724-2158; acenti@partners.org

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: Participants will not know which group (smart phone or embedded link) is the intervention vs. control group.
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Partners Healthcare

Model Details: Intervention- one group will use a smartphone application to fill out surveys while the other group fills out surveys via an emailed embedded link.

Study Record Dates

• First Submitted: September 23, 2019
• First Posted: September 25, 2019
• Study Start: October 1, 2019
• Primary Completion: January 30, 2020
• Study Completion: February 28, 2020
• Last Updated: September 30, 2019

Record last verified: 2019-09

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)